The Safety & Efficacy of Combination BMS-201038 (AEGR-733) & Ezetimibe vs. Monotherapy in Moderate Hypercholesterolemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Barry Lubin, MD
Hampton Roads Center for Clinical Research
Principal Investigator - Eli Roth, MD
Sterling Research Group, LTD
Principal Investigator - Jackson Downey, MD
Jacksonville Center For Clinical Research
Principal Investigator - James McKenney, Pharm D
National Clinical Research
Principal Investigator - Paul Grena, MD
Cardiology Consultants of Philadelphia
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pharmanet, Inc
Princeton, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 31 Jan 2007
- Completion
- 31 Jan 2007
- Last update posted
- 4 Mar 2014
- Registered enrollment
- 60
- Registry id
- NCT00405067
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.